Valaciclovir as a single dose during prodrome of herpes facialis: A pilot randomized double-blind clinical trial

British Journal of Dermatology

Volumn 148, Issue 1, 2003, Pages 142-146

  Chosidow, O ^d   Drouault, Y ^a   Garraffo, R ^b   Veyssier, P ^c  

^a Hôpital Tarnier Cochin ^*  (France)

^b PASTEUR HOSPITAL   (France)

^c Centre Hospitalier Compiegne   (France)

^d NONE

Author keywords

Herpes facialis; Randomized clinical trial; Valaciclovir

Indexed keywords

VALACICLOVIR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HERPES LABIALIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HERPES LABIALIS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PRODRUGS; RECURRENCE; TREATMENT OUTCOME; VALINE;

EID: 0037240527     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05062.x     Document Type: Article

References (13)

1. Spruance SL, Overall JC Jr, Kern ER et al. The natural history of recurrent herpes simplex labialis. N Engl J Med 1977; 297: 69-75.
2. Vander Straten M, Carrasco D, Lee P, Tyring SK. A review of antiviral therapy for herpes labialis. Arch Dermatol 2001; 137: 1232-5.
3. Balfour HH. Antiviral drugs. N Engl J Med 1999; 340: 1255-68.
4. Fiddian PA, Yeo JM, Stubbings R, Dean D. Successful treatment of herpes labialis with topical acyclovir. Br Med J 1983; 286: 1699-701.
5. Chosidow O, Drouault Y, Leconte-Veyriac F et al. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial. Br J Dermatol 2001; 144: 818-24.
6. Higgins CR, Schofield JK, Tatnall FM, Leigh IM. Natural history, management and complications of herpes labialis. J Med Virol Suppl 1993; 1: 22-6.
7. ANAES. Prise en charge de l'herpès cutanéo-muqueux chez l'immunocompétent. URL: http://www.anaes.fr
8. Spruance SL, Rea TL, Thoming C et al. Penciclovir cream for the treatment of herpes simplex labialis: a randomized multicenter, double-blind, placebo-controlled trial. JAMA 1997; 277: 1374-9.
9. Sacks S, Thisted RA, Jones TM et al. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol 2001; 45: 222-30.
10. Raborn GW, McGaw WT, Grace M et al. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study. J Am Dent Assoc 1987; 115: 38-42.
11. Spruance SL, Stewart JCB, Rowe NH et al. Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis 1990; 161: 185-90.
12. Wald A, Carrell D, Remington M et al. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 2002; 34: 944-8.
13. Leone P, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002; 34: 958-62.